Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121473352 | 12147335 | 2 | F | 2015 | 20160822 | 20160304 | 20160830 | EXP | CA-AMGEN-CANSP2016026213 | AMGEN | 38.00 | YR | A | F | Y | 0.00000 | 20160830 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121473352 | 12147335 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 121473352 | 12147335 | 2 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 121473352 | 12147335 | 3 | SS | VENLAFAXINE HYDROCHLORIDE. | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, QD | 0 | 150 | MG | QD | |||||||
| 121473352 | 12147335 | 4 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 300 MG, QD | 0 | 300 | MG | TABLET | QD | ||||||
| 121473352 | 12147335 | 5 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 121473352 | 12147335 | 6 | C | REACTINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 121473352 | 12147335 | 7 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, QD | 0 | 150 | MG | QD | |||||||
| 121473352 | 12147335 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121473352 | 12147335 | 1 | Rheumatoid arthritis |
| 121473352 | 12147335 | 2 | Rheumatoid arthritis |
| 121473352 | 12147335 | 3 | Product used for unknown indication |
| 121473352 | 12147335 | 4 | Product used for unknown indication |
| 121473352 | 12147335 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121473352 | 12147335 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121473352 | 12147335 | Anaphylactic shock | |
| 121473352 | 12147335 | Arthritis | |
| 121473352 | 12147335 | Drug effect decreased | |
| 121473352 | 12147335 | Drug effect incomplete | |
| 121473352 | 12147335 | Drug hypersensitivity | |
| 121473352 | 12147335 | Drug ineffective | |
| 121473352 | 12147335 | Drug intolerance | |
| 121473352 | 12147335 | Hepatic fibrosis | |
| 121473352 | 12147335 | Hypertension | |
| 121473352 | 12147335 | Insomnia | |
| 121473352 | 12147335 | Pain | |
| 121473352 | 12147335 | Rash | |
| 121473352 | 12147335 | Seronegative arthritis | |
| 121473352 | 12147335 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121473352 | 12147335 | 1 | 201602 | 0 |